Sara Tasneem, MD
Hematology & Oncology · Little Rock, ARNPI 1053711333
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.5% of the total across 130 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 40 manufacturers, the largest accounting for just 9.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,810, 7.7 times the $364 reported in 2023. That places this record below the midpoint for hematology & oncology clinicians in AR, where the typical reported total is $4,667.
Across 130 payments — averaging $27.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$334
- Incyte Corporation$325
- E.r. Squibb & Sons, L.L.C.$215
- Beone Medicines USA, Inc.$210
- Sanofi$197
- Merck$197
- plus $2K from 34 others
What the payments were for
- Food & beverage$3,29893%
- Education$2677%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 13 | $334 |
| Incyte Corporation | 10 | $325 |
| E.r. Squibb & Sons, L.L.C. | 4 | $215 |
| Beone Medicines USA, Inc. | 4 | $210 |
| Sanofi | 2 | $197 |
| Merck | 10 | $197 |
| GSK | 6 | $193 |
| AstraZeneca(2 entities) | 10 | $192 |
| Gilead(2 entities) | 4 | $157 |
| Pfizer | 9 | $144 |
| Novartis | 7 | $142 |
| Astellas Pharma US Inc | 1 | $125 |
| Seagen Inc. | 1 | $99 |
| EMD Serono, Inc. | 4 | $89 |
| Ipsen Biopharmaceuticals, Inc | 3 | $75 |
| Daiichi Sankyo Inc. | 3 | $75 |
| Johnson & Johnson | 4 | $72 |
| AVEO Pharmaceuticals, Inc. | 3 | $68 |
| Eisai Inc. | 3 | $65 |
| Exelixis Inc. | 3 | $64 |
| Sobi, Inc | 2 | $55 |
| Pharmaessentia USA Corporation | 2 | $46 |
| Genentech USA, Inc. | 2 | $44 |
| Bristol Myers Squibb | 2 | $42 |
| Puma Biotechnology, Inc. | 2 | $40 |
| Caris MPI, Inc. | 2 | $30 |
| Boehringer Ingelheim | 1 | $26 |
| Lilly USA, LLC | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Alnylam Pharmaceuticals Inc. | 1 | $21 |
| Bayer | 1 | $20 |
| Spectrum Pharmaceuticals Inc. | 1 | $18 |
| Array Biopharma Inc | 1 | $18 |
| Servier Pharmaceuticals LLC | 1 | $18 |
| Geron Corporation | 1 | $17 |
| Rigel Pharmaceuticals, Inc. | 1 | $17 |
| Pharmacosmos Therapeutics Inc. | 1 | $16 |
| Kyowa Kirin, Inc. | 1 | $15 |
| Deciphera Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,565 in reported general payments places this provider in the 45th percentile of 92 hematology & oncology providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology & oncology in Little Rock
- Frits van RheeLittle Rock$218K
- Appalanaidu SasapuLittle Rock$63K
- Peter EmanuelLittle Rock$53K
- Brad BaltzLittle Rock$25K
- Carolina SchinkeLittle Rock$23K
- Pooja MotwaniLittle Rock$21K
- Naveen YarlagaddaLittle Rock$18K
- Joseph BeckLittle Rock$16K
- Konstantinos ArnaoutakisLittle Rock$12K
- Abhijit GodboleLittle Rock$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.